CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Walter, Dagmar ^a   Satheesha, Sampoorna ^a   Albrecht, Patrick ^a   Bornhauser, Beat C ^a   D'Alessandro, Valentina ^a   Oesch, Susanne M ^a,b   Rehrauer, Hubert ^c   Leuschner, Ivo ^d   Koscielniak, Ewa ^e   Gengler, Carole ^f   Moch, Holger ^f   Bernasconi, Michele ^a   Niggli, Felix K ^a   Schäfer, Beat W ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF KIEL   (Germany)

^e OLGAHOSPITAL   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; GROWTH FACTOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RNA; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADIPOCYTE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENICITY; CELL ADHESION; CELL DIFFERENTIATION; CELL POPULATION; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE MARKER; EMBRYONAL RHABDOMYOSARCOMA; ENRICHMENT CULTURE; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MARKER GENE; MESENCHYMAL STEM CELL; MOUSE; MUSCLE CELL; NERVE CELL; NONHUMAN; OVERALL SURVIVAL; PROGNOSIS; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CULTURE TECHNIQUE; GENETICS; PATHOLOGY; SURVIVAL RATE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; MICE; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; RHABDOMYOSARCOMA, EMBRYONAL; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955940627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019506     Document Type: Article

References (50)

1. Lobo NA, Shimono Y, Qian D, Clarke MF, (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699.
2. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
4. Singh S, Dirks PB, (2007) Brain tumor stem cells: identification and concepts. Neurosurg Clin N Am 18: 31-38, viii.
5. Todaro M, Francipane MG, Medema JP, Stassi G, (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-2162.
6. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133-137.
7. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, et al. (2009) Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 106: 16281-16286.
8. Dean M, Fojo T, Bates S, (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
9. Jiang X, Gwye Y, Russell D, Cao C, Douglas D, et al. (2010) CD133 expression in chemo-resistant Ewing sarcoma cells. BMC Cancer 10: 116.
10. Todaro M, Perez Alea M, Scopelliti A, Medema JP, Stassi G, (2008) IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 7: 309-313.
11. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, et al. (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells 28: 17-28.
12. Morrison SJ, Spradling AC, (2008) Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132: 598-611.
13. De Giovanni C, Landuzzi L, Nicoletti G, Lollini PL, Nanni P, (2009) Molecular and cellular biology of rhabdomyosarcoma. Future Oncol 5: 1449-1475.
14. Gregorio A, Corrias MV, Castriconi R, Dondero A, Mosconi M, et al. (2008) Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. Histopathology 53: 73-80.
15. McDowell HP, (2003) Update on childhood rhabdomyosarcoma. Arch Dis Child 88: 354-357.
16. Hirotsu M, Setoguchi T, Matsunoshita Y, Sasaki H, Nagao H, et al. (2009) Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. Br J Cancer 101: 2030-2037.
17. Merlino G, Khanna C, (2007) Fishing for the origins of cancer. Genes Dev 21: 1275-1279.
18. Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, et al. (2000) Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 3: 986-991.
19. Wachtel M, Runge T, Leuschner I, Stegmaier S, Koscielniak E, et al. (2006) Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J Clin Oncol 24: 816-822.
20. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
21. Shu Q, Wong KK, Su JM, Adesina AM, Yu LT, et al. (2008) Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells 26: 1414-1424.
22. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, et al. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402.
23. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.
24. Ding W, Mouzaki M, You H, Laird JC, Mato J, et al. (2009) CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology 49: 1277-1286.
25. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, et al. (2007) Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43: 935-946.
26. Miki J, Furusato B, Li H, Gu Y, Takahashi H, et al. (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-3161.
27. Suva ML, Riggi N, Stehle JC, Baumer K, Tercier S, et al. (2009) Identification of cancer stem cells in Ewing's sarcoma. Cancer Res 69: 1776-1781.
28. Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, et al. (2011) CD133 suppresses neuroblastoma cell differentiation via signal pathway modification. Oncogene 30: 97-105.
29. Bidlingmaier S, Zhu X, Liu B, (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86: 1025-1032.
30. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
31. Babu H, Cheung G, Kettenmann H, Palmer TD, Kempermann G, (2007) Enriched monolayer precursor cell cultures from micro-dissected adult mouse dentate gyrus yield functional granule cell-like neurons. PLoS ONE 2: e388.
32. Bouchard F, Paquin J, (2009) Skeletal and cardiac myogenesis accompany adipogenesis in P19 embryonal stem cells. Stem Cells Dev 18: 1023-1032.
33. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
34. Scientific T, (2009) Human Mesenchymal Stem Cell Protocol: Oil Red O Staining of Adipogenic Cultures. Thermo Scientific https://www.thermo.com/eThermo/CMA/PDFs/Various/File_4336.pdf (13.01.2011).
35. Angello JC, Stern HM, Hauschka SD, (1997) P19 embryonal carcinoma cells: a model system for studying neural tube induction of skeletal myogenesis. Dev Biol 192: 93-98.
36. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C, (2006) Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319.
37. McBurney MW, (1993) P19 embryonal carcinoma cells. Int J Dev Biol 37: 135-140.
38. Skerjanc IS, (1999) Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc Med 9: 139-143.
39. Dantonello TM, Int-Veen C, Winkler P, Leuschner I, Schuck A, et al. (2008) Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol 26: 406-413.
40. Larsson LG, Henriksson MA, (2010) The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 316: 1429-1437.
41. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR, (2003) Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22: 7989-7997.
42. Robson EJ, He SJ, Eccles MR, (2006) A PANorama of PAX genes in cancer and development. Nat Rev Cancer 6: 52-62.
43. Young AP, Wagers AJ, (2010) Pax3 induces differentiation of juvenile skeletal muscle stem cells without transcriptional upregulation of canonical myogenic regulatory factors. J Cell Sci 123: 2632-2639.
44. Astolfi A, De Giovanni C, Landuzzi L, Nicoletti G, Ricci C, et al. (2001) Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 274: 139-149.
45. Charytonowicz E, Cordon-Cardo C, Matushansky I, Ziman M, (2009) Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279: 126-136.
46. Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ, et al. (2006) Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66: 6936-6946.
47. Lae M, Ahn EH, Mercado GE, Chuai S, Edgar M, et al. (2007) Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol 212: 143-151.
48. Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, et al. (2004) Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64: 5539-5545.
49. Tajbakhsh S, Vivarelli E, Cusella-De Angelis G, Rocancourt D, Buckingham M, et al. (1994) A population of myogenic cells derived from the mouse neural tube. Neuron 13: 813-821.
50. Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, et al. (2008) Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J 175: 69-75.